MedPath

AVVA PHARMACEUTICALS LTD

AVVA PHARMACEUTICALS LTD logo
🇨🇾Cyprus
Ownership
Private
Employees
11
Market Cap
-
Website
https://www.avvapharma.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

2 Phases

Phase 2:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 2
1 (50.0%)

Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis

Phase 2
Recruiting
Conditions
Candidal Vulvovaginitis (ICD-10 Code: B37.3)
Vulvovaginal Candidiasis (VVC)
Interventions
Drug: Clotrimazole+Lactulose.
Drug: Canesten (Clotrimazole)
First Posted Date
2025-02-19
Last Posted Date
2025-02-19
Lead Sponsor
AVVA Pharmaceuticals Ltd.
Target Recruit Count
264
Registration Number
NCT06835361
Locations
🇧🇾

Healthcare Institution "1st Central District Polyclinic of the Central District of Minsk", Minsk, Belarus

🇧🇾

Healthcare Institution "14th Central District Polyclinic of the Partizansky District of Minsk", Minsk, Belarus

🇧🇾

Healthcare Institution "2nd Central District Polyclinic of the Frunzensky District of Minsk", Minsk, Belarus

and more 4 locations

Efficacy of the Dietary Food Supplement ALCOFILTRUM in Alleviating Alcohol Hangover Symptoms

Not Applicable
Recruiting
Conditions
Alcohol Intoxication
Alcohol Drinking
First Posted Date
2023-03-07
Last Posted Date
2023-03-07
Lead Sponsor
AVVA Pharmaceuticals Ltd.
Target Recruit Count
60
Registration Number
NCT05757089
Locations
🇧🇾

Clinical Emergency Hospital, Minsk, Belarus

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.